The Vanguard Group 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 3,319,492 8.200% |
781,460 (+30.79%) |
Filing |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,538,032 7.490% |
2,538,032 (New Position) |
Filing |